No Data
Guangdong Marubi Biotechnology Co., Ltd.'s (SHSE:603983) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?
guangdong marubi biotechnology (603983.SH): Intends to change the securities abbreviation to "Marubi Biology".
Gelonghui December 5th | guangdong marubi biotechnology (603983.SH) announced that the company held the fifth session of the board of directors on December 5, 2024, to deliberate and approve the proposal on the proposed change of the company's stock abbreviation, agreeing to change the company's stock abbreviation from "guangdong marubi biotechnology" to "guangdong marubi biology", while the company's stock code "603983" remains unchanged.
Guosen: The wave of mergers and acquisitions in the retail industry is rising, an important growth paradigm for enterprises in the era of existing inventory.
From the perspective of leading listed companies, a significant amount of capital operation and diversified management experience has been accumulated in recent years. With the increasing demand for exits in the primary market, many high-quality consumer symbols have also provided listed companies with good acquisition and integration opportunities.
Guangdong Marubi Biotechnology (603983.SH) distributed 0.25 yuan per share in the first three quarters, with the equity registration date on November 15th.
Guangdong Marubi Biotechnology (603983.SH) issued an announcement that the company will implement equity distribution for the first three quarters of 2024, per share...
Guosen: In 2024, the november 11 shopping festival-related e-commerce promotion overall grew steadily, with intensified differentiation among beauty brands.
As of October 30, 2024, the total sales of november 11 shopping festival-related reached 845 billion (including comprehensive e-commerce monitoring period: October 14 to October 30, live e-commerce monitoring period: October 8 to October 30), breaking the historical sales record for October.
Guangdong Marubi Biotechnology's (SHSE:603983) Earnings Are Of Questionable Quality
Guangdong Marubi Biotechnology (SHSE:603983) May Have Issues Allocating Its Capital
No Data
